Arthur Mader

Feldkirch, 6800, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Management of dyslipidaemia in patients with comorbidities-facing the challenge: heart failure.

Management of dyslipidaemia in patients with comorbidities-facing the challenge: heart failure.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: February 06, 2026

Prognostic value of circulating glypican-4 in chronic heart failure.

Prognostic value of circulating glypican-4 in chronic heart failure.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: September 28, 2025

Interpretable type 2 diabetes incidence prediction with AutoScore: A model based on standard clinical parameters.

Interpretable type 2 diabetes incidence prediction with AutoScore: A model based on standard clinical parameters.

Journal: International journal of medical informatics

Published: July 08, 2025

Curriculum interventional cardiology-Austria.

Curriculum interventional cardiology-Austria.

Journal: Wiener klinische Wochenschrift

Published: October 23, 2024

Three decades of glucose-lowering therapy in patients at high cardiovascular risk - A real-world analysis.

Three decades of glucose-lowering therapy in patients at high cardiovascular risk - A real-world analysis.

Journal: Diabetes, obesity & metabolism

Published: September 06, 2024

Remnant cholesterol and long-term incidence of death in coronary artery disease patients.

Remnant cholesterol and long-term incidence of death in coronary artery disease patients.

Journal: Atherosclerosis

Published: June 17, 2024

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis.

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis.

Journal: Scientific reports

Published: April 24, 2024

Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence.

Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence.

Journal: International journal of molecular sciences

Published: March 20, 2024

25 years of lipid-lowering therapy: secular trends in therapy of coronary patients.

25 years of lipid-lowering therapy: secular trends in therapy of coronary patients.

Journal: Wiener klinische Wochenschrift

Published: February 20, 2024

Bempedoic Acid: How Will It Shape the Future Lipid-Lowering Landscape? Mode of Action, Evidence, and Clinical Use.

Bempedoic Acid: How Will It Shape the Future Lipid-Lowering Landscape? Mode of Action, Evidence, and Clinical Use.

Journal: Cardiology

Published: October 06, 2023

Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

Journal: Clinical biochemistry

Published: June 28, 2023

Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.

Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.

Journal: Data in brief

Published: March 03, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026